Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR)

August 10, 2026 6:44 AM
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $20.00 price target on Vir Biotechnology (NASDAQ: VIR).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments